Move to topTop

TOKYO, JAPAN - October 22, 2020 - Terumo Corporation (TSE: 4543) today announced the creation of the company's global Group Music in conjunction with Terumo's 100th anniversary in 2021.

The composition is based on the concept "Let's respect the past, dream for the future, and open new doors together." The track is composed by Mr. Akira Senju, a highly regarded Japanese composer and recipient of numerous awards and honors.

Mr. Senju's 35th anniversary album which was released on October 21 includes 'TOGETHER', one of the Terumo Group Music. Portraying Terumo's pursuit to be together with society, the Group Music will be shared all over the world.

"Since our establishment in 1921, Terumo has proudly fostered a unique culture of excellence over the years," said Takayoshi Mimura, Chairman of the Board, Terumo Corporation. "By making great progress for another 100 years, we will continue to strive for our Group Mission - Contributing to Society through Healthcare. The music we reveal today will guide us on our journey."

About Terumo

Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of “Contributing to Society through Healthcare.” Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

 

Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.